| Afatinib |
ENSG00000135253.9 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000135253.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000153363.8 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000160336.10 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000160336.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000163364.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000170590.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000171671.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000174171.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000175147.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000175147.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000175147.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000177410.8 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000177757.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000177757.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000177788.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000177993.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000179406.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000179406.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000179523.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000179523.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000180712.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000182109.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000182404.6 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000182648.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000183535.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000184068.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000184068.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000184274.3 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000185168.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000185186.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000185904.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000186019.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000187156.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000187621.10 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000187904.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000188424.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000188660.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000189196.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000189238.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000196566.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000196960.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000196960.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000197332.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000197558.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000197989.9 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000198106.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000198221.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000203280.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000203280.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000203288.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000203288.3 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000203325.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000203325.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000203356.2 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000203499.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000203499.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000203635.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000203801.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000203808.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000203875.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000204044.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000204588.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000204625.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000204666.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000204706.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000204815.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000204832.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000204832.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000205037.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000205056.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000205266.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000205444.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000205488.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000205559.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000205662.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000205885.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000205890.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000205890.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000205959.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000206028.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000206417.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000212163.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000213468.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000213468.3 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000213863.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000213904.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000214049.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000214293.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000214353.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000214353.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000214353.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000214401.4 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000214432.5 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000214546.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000214559.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000214733.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000214773.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000214851.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000214851.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000214894.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000214955.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000215068.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000215159.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000215241.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000215244.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000215244.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000215458.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000215483.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000215483.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000215841.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000215841.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000215841.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000215863.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000219665.4 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000220161.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000222043.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000222044.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000223379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000223396.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000223442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000223462.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000223482.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000223485.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000223525.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000223571.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000223576.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000223685.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000223697.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000223711.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000223711.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000223759.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000223784.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000223791.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000223804.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000223813.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000223842.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000223842.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000223842.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000223855.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000223882.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000223884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000223956.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000223960.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000223975.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000224017.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000224020.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000224020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000224079.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000224079.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000224081.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000224081.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000224081.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000224189.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000224220.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000224281.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000224356.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000224384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000224387.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000224460.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000224468.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000224481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000224490.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000224509.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000224577.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000224606.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000224621.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000224621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000224649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000224652.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000224666.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000224687.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000224699.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000224707.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000224713.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000224729.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000224764.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000224794.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000224805.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000224805.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000224812.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000224822.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000224875.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000224883.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000224888.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000224888.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000224888.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000224930.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000224934.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000224950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000224959.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000224961.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000224961.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000224969.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000224975.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000224984.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000224992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000225030.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000225039.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000225057.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000225057.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000225075.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000225076.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000225083.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000225096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000225111.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000225140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000225140.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000225152.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000225173.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000225187.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000225205.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000225235.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000225300.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000225311.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000225311.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000225335.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000225335.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000225408.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000225439.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000225442.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000225465.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000225511.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000225532.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000225555.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000225572.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000225578.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000225578.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000225602.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000225652.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000225721.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000225744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000225760.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000225762.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000225767.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000225767.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000225850.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000225889.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000225891.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000225956.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000225982.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000226009.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000226017.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000226051.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000226067.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000226091.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000226101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000226155.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000226155.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000226194.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000226272.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000226276.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000226281.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000226287.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000226287.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000226287.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000226291.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000226310.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000226328.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000226328.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000226330.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000226330.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000226332.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000226349.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000226352.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000226363.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000226363.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000226367.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000226377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000226380.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000226386.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000226598.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000226637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000226645.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000226673.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000226696.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000226741.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000226754.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000226754.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000226758.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000226772.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000226791.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000226792.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000226800.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000226803.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000226803.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000226816.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000226852.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000226889.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000226890.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000226935.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000226950.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000226963.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000227006.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000227036.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000227045.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000227050.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000227070.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000227071.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000227071.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000227071.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000227117.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000227165.3 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000227189.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000227192.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000227210.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000227215.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000227218.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000227237.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000227359.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000227388.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000227403.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000227431.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000227456.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000227479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000227482.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000227484.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000227486.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000227487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000227496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000227527.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000227527.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000227533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000227542.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000227598.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000227598.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000227598.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000227617.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000227617.4 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000227619.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000227627.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000227681.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000227704.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000227719.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000227726.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000227733.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000227748.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000227885.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000227885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000227885.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000227885.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000227906.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000228043.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000228072.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000228084.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000228084.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000228113.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000228124.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000228126.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000228140.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000228176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000228192.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000228201.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000228201.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000228203.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000228204.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000228204.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000228237.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000228237.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000228251.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000228261.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000228288.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000228288.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000228290.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000228293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000228313.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000228315.7 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000228327.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000228393.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000228404.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000228437.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000228478.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000228481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000228487.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000228526.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000228544.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000228544.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000228598.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000228613.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000228624.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000228643.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000228649.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000228679.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000228719.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000228737.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000228737.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000228748.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000228763.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000228775.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000228791.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000228812.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000228865.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000228865.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000228886.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000228917.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000228917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000228918.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000228939.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000228952.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000229017.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000229021.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000229122.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000229127.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000229127.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000229140.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000229152.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000229153.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000229154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000229178.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000229190.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000229196.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000229228.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000229272.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000229291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000229294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000229311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000229373.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000229373.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000229380.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000229401.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000229512.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000229512.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000229531.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000229582.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000229582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000229618.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000229656.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000229656.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000229660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000229660.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000229666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000229666.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000229702.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000229739.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000229766.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000229782.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000229801.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000229821.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000229839.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000229841.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000229852.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000229891.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000229952.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000229956.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000229980.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000229990.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000229999.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000230005.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000230058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000230061.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000230074.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000230084.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000230091.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000230140.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000230176.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000230184.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000230289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000230319.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000230392.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000230423.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000230423.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000230439.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000230470.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000230489.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000230498.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000230499.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000230499.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000230499.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000230506.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000230536.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000230590.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000230613.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000230633.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000230658.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000230658.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000230679.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000230679.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000230698.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000230698.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000230699.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000230725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000230732.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000230732.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000230753.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000230798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000230817.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000230825.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000230836.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000230899.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000230922.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000231028.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000231057.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000231107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000231113.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000231187.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000231187.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000231226.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000231305.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000231310.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000231327.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000231329.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000231335.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000231367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000231401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000231407.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000231439.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000231483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000231530.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000231551.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000231551.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000231607.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000231651.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000231654.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000231690.2 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000231691.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000231709.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000231721.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000231734.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000231760.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000231770.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000231789.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000231806.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000231865.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000231865.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000231868.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000231871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000231881.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000231881.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000231920.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000231920.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000231944.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000231966.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000231969.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000231976.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000232019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000232034.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000232077.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000232082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000232082.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000232093.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000232117.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000232118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000232118.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000232118.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000232124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000232131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000232131.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000232151.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000232151.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000232160.2 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000232184.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000232194.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000232224.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000232290.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000232311.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000232336.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000232336.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000232336.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000232354.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000232354.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000232386.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000232415.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000232442.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000232453.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000232455.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000232487.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000232490.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000232527.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000232545.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000232586.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000232611.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000232613.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000232623.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000232642.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000232645.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000232655.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000232677.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000232696.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000232725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000232855.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000232892.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000232900.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000232912.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000232977.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000233006.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000233016.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000233033.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000233033.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000233038.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000233058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000233058.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000233108.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000233110.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000233117.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000233143.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000233154.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000233184.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000233237.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000233242.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000233246.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000233250.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000233261.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000233303.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000233368.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000233387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000233411.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000233427.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000233451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000233483.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000233483.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000233509.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000233517.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000233521.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000233527.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000233536.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000233602.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000233627.2 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000233654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000233654.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000233672.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000233693.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000233694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000233695.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000233695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000233695.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000233775.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000233775.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000233776.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000233799.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000233806.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000233806.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000233834.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000233834.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000233845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000233848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000233862.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000233862.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000233871.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000233895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000233895.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000233903.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000233930.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000233967.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000234019.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000234062.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000234062.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000234091.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000234111.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000234147.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000234174.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000234174.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000234181.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000234185.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000234199.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000234206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000234208.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000234215.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000234222.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000234235.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000234235.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000234245.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000234252.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000234261.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000234290.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000234292.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000234350.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000234428.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000234456.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000234509.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000234610.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000234614.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000234650.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000234650.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000234676.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000234678.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000234678.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000234678.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000234684.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000234694.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000234722.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000234772.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000234773.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000234899.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000234900.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000234912.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000234915.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000234917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000234998.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000234998.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000235005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000235077.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000235078.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000235117.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000235146.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000235159.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000235192.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000235204.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000235236.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000235262.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000235381.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000235387.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000235398.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000235408.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000235423.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000235453.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000235527.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000235529.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000235529.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000235530.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000235565.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000235609.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000235652.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000235659.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000235663.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000235724.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000235760.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000235772.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000235781.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000235823.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000235823.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000235837.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000235837.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000235852.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000235880.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000235902.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000235903.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000235908.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000235910.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000235939.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000235947.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000235954.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000235958.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000235999.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000236003.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000236008.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000236021.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000236064.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000236088.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000236094.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000236095.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000236095.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000236137.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000236153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000236194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000236199.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000236230.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000236262.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000236305.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000236347.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000236364.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000236383.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000236394.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000236394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000236432.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000236432.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000236467.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000236536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000236537.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000236537.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000236545.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000236591.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000236601.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000236617.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000236641.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000236651.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000236703.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000236703.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000236711.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000236711.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000236740.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000236743.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000236751.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000236778.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000236780.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000236830.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000236833.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000236889.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000236889.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000236896.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000236914.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000236914.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000236935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000236943.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000237036.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000237063.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000237073.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000237149.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000237152.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000237188.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000237222.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000237234.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000237248.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000237327.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000237336.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000237356.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000237357.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000237373.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000237404.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000237438.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000237453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000237485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000237489.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000237491.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000237502.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000237520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000237523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000237529.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000237588.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000237596.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000237605.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000237646.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000237689.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000237705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000237707.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000237756.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000237756.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000237772.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000237772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000237773.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000237807.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000237819.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000237836.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000237934.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000237938.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000237940.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000237945.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000238005.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000238068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000238107.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000238113.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000238123.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000238141.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000238210.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000238221.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000238280.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000239213.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000239335.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000239335.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000239377.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000239508.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000239523.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000239593.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000239653.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000239653.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000239653.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000239664.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000239664.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000239828.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000239920.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000239920.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000240006.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000240032.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000240211.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000240211.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000240241.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000240254.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000240288.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000240291.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000240350.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000240373.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000240401.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000240453.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000240453.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000240499.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000240541.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000240549.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000240553.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000240731.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000240758.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000240875.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000240875.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000240990.5 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000241014.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000241180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000241313.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000241316.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000241570.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000241570.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000241599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000241684.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000241764.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000241818.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000241912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000241933.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000242094.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000242136.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000242190.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000242282.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000242370.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000242375.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000242474.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000242516.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000242540.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000242767.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000242828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000242861.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000242861.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000243055.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000243069.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000243350.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000243368.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000243479.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000243533.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000243636.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000243701.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000243885.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000244137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000244161.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000244252.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000244265.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000244268.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000244286.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000244302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000244649.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000244733.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000245025.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000245067.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000245080.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000245105.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000245148.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000245281.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000245293.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000245330.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000245466.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000245532.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000245532.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000245534.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000245571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000245571.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000245598.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000245685.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000245748.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000245928.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000246067.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000246090.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000246130.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000246145.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000246174.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000246228.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000246263.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000246263.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000246334.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000246363.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000246465.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000246523.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000246526.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000246528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000246548.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000246560.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000246582.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000246582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000246640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000246695.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000246740.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000246790.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000246898.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000246898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000246898.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000247095.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000247095.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000247151.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000247287.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000247416.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000247498.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000247572.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000247679.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000247679.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000247774.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000247775.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000247809.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000247809.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000247853.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000247925.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000248008.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000248027.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000248079.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000248079.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000248092.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000248112.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000248125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000248138.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000248152.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000248275.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000248371.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000248416.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000248429.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000248445.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000248456.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000248468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000248476.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000248494.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000248576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000248663.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000248664.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000248668.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000248693.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000248714.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000248724.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000248774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000248779.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000248932.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000248936.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000248954.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000248954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000248968.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000248996.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000249042.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000249173.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000249199.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000249207.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000249234.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000249241.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000249275.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000249307.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000249395.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000249395.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000249412.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000249417.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000249476.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000249532.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000249550.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000249593.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000249604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000249631.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000249637.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000249641.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000249655.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000249669.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000249700.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000249738.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000249740.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000249753.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000249786.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000249807.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000249825.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000249885.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000249955.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000249996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000250015.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000250039.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000250046.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000250072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000250131.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000250132.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000250234.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000250260.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000250295.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000250320.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000250326.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000250362.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000250451.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000250509.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000250522.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000250541.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000250548.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000250590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000250592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000250604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000250608.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000250608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000250614.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000250634.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000250698.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000250714.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000250734.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000250765.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000250829.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000250889.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000250889.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000250891.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000250903.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000250934.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000250948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000250950.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000250950.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000250994.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000251002.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000251003.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000251003.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000251018.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000251072.2 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000251138.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000251169.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000251175.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000251221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000251292.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000251307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000251307.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000251323.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000251350.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000251396.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000251432.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000251432.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000251455.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000251603.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000251611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000251615.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000251665.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000251666.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000251666.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000251675.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000251675.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000251687.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000251687.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000253121.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000253174.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000253174.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000253182.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000253302.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000253347.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000253390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000253390.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000253392.2 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000253408.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000253476.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000253476.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000253477.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000253508.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000253522.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000253530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000253553.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000253632.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000253671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000253701.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000253706.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000253708.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000253708.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000253716.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000253737.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000253773.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000253824.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000253837.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000253837.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000253842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000253875.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000253875.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000253878.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000253878.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000253917.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000253925.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000253929.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000253930.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000253944.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000253948.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000253965.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000253972.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000253972.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000253986.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000253986.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000254003.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000254024.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000254039.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000254099.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000254109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254109.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000254142.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254153.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000254154.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254180.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000254204.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000254205.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000254208.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000254223.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000254226.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254231.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254231.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000254248.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000254258.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000254258.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000254266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254267.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254286.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000254286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254317.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000254319.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254333.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254362.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000254363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000254409.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000254414.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000254414.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000254418.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000254418.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000254433.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000254473.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000254484.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000254495.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000254528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254539.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254563.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000254604.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000254607.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000254610.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000254632.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000254632.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000254691.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000254693.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000254694.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000254694.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000254699.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000254710.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000254710.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254718.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000254731.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000254777.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254777.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000254791.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000254812.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000254847.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000254854.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000254854.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000254854.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000254898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254929.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000254929.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000254932.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000254936.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000254973.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000254973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000254990.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000255008.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000255031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000255031.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000255045.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000255050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000255090.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000255090.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000255092.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000255118.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000255120.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000255124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000255139.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000255142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000255145.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000255148.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000255158.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000255160.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000255182.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000255241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000255247.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000255248.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000255318.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000255321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000255334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000255355.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000255362.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000255367.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000255367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000255400.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000255474.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000255503.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000255520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000255557.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000255565.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000255571.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000255693.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000255717.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000255774.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000255857.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000255886.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000255893.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000255959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000255966.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000255966.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000255968.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000255970.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000255989.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000256001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000256006.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000256050.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000256084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000256092.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000256115.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000256196.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000256248.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000256288.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000256381.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000256443.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000256448.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000256448.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000256582.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000256650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000256690.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000256739.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000256789.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000256789.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000256862.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000256894.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000257038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000257084.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000257137.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000257167.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000257176.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000257202.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000257221.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000257256.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000257264.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000257354.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000257391.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000257452.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000257497.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000257527.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000257527.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000257543.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000257551.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000257568.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000257588.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000257588.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000257636.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000257660.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000257671.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000257671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000257681.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000257681.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000257698.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000257830.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000257859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000257894.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000257913.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000257940.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000257947.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000258044.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000258099.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000258101.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000258122.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000258302.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000258303.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000258317.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000258323.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000258412.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000258412.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000258413.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000258424.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000258442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000258454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000258455.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000258479.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000258479.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000258515.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000258551.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000258556.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000258586.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000258593.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000258593.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000258593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000258630.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000258646.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000258647.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000258658.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000258689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000258725.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000258777.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000258789.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000258791.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000258803.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000258815.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000258824.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000258882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000258884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000258891.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000258903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000258929.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000258940.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000259039.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000259065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000259081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000259083.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000259087.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000259088.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000259125.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000259138.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000259146.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000259163.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000259172.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000259172.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000259201.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000259212.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000259212.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000259222.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000259225.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000259250.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000259280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000259296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000259322.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000259327.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000259343.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000259349.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000259354.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000259354.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000259359.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000259365.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000259380.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000259417.2 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000259420.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000259426.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000259450.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000259456.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000259457.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000259462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000259469.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000259469.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000259474.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000259523.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000259523.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000259563.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000259595.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000259604.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000259617.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000259635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000259644.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000259644.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000259644.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000259645.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000259656.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000259659.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000259659.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000259663.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000259678.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000259705.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000259727.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000259732.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000259732.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000259744.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000259763.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000259767.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000259772.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000259775.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000259792.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000259796.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000259814.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000259871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000259883.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000259891.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000259899.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000259935.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000259942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000259959.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000259969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260000.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000260018.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000260022.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000260052.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000260063.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000260065.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000260081.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000260095.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000260118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260145.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000260166.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000260167.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000260173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260173.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000260179.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000260186.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000260194.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000260196.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260213.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000260249.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000260252.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000260257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000260276.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000260277.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000260285.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000260296.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000260328.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000260329.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260336.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000260352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260361.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000260368.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000260368.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000260394.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000260396.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000260398.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260411.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000260411.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000260418.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000260418.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000260425.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000260436.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000260439.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000260447.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000260448.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000260464.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000260464.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000260468.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000260475.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000260495.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000260509.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000260517.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000260536.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000260536.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000260558.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000260558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000260577.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260583.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000260586.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000260588.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000260591.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000260592.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000260601.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000260614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260646.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000260655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260655.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000260661.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000260664.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000260708.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000260708.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000260711.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000260742.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000260751.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000260777.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000260778.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000260798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260814.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000260823.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000260831.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260877.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000260896.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000260910.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000260910.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000260912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000260931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000260932.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000260953.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000260979.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000261000.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000261003.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000261008.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000261019.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000261024.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000261055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000261055.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000261068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000261079.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000261087.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000261096.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000261104.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000261168.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000261168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000261183.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000261183.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000261200.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000261220.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000261238.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000261266.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000261267.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000261280.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000261280.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000261280.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000261286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000261286.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000261286.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000261291.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000261295.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000261329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000261341.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000261399.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000261399.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000261404.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000261416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000261428.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000261438.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000261485.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000261490.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000261521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000261533.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000261534.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000261534.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000261560.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000261560.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000261572.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000261582.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000261584.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000261597.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000261618.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000261632.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000261633.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000261654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000261654.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000261654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000261670.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000261685.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000261685.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000261690.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000261693.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000261729.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000261766.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000261775.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000261777.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000261798.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000261801.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000261804.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000261823.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000261838.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000261839.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000261864.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000261886.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000261916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000262094.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000262119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000262152.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000262155.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000262222.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000262265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000262265.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000262294.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000262296.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000262319.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000262343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000262362.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000262678.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000262714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000262810.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000262823.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000262873.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000262888.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000262952.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000262952.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000262979.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000263013.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000263013.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000263096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000263105.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000263220.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000263280.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000263325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000263327.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000263388.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000263624.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000263680.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000263680.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000263718.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000263731.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000263847.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000263874.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000263893.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000263923.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000264007.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000264026.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000264043.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000264043.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000264083.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000264107.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000264107.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000264107.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000264222.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000264290.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000264304.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000264365.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000264448.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000264527.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000264569.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000264575.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000264575.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000264672.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000264729.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000264745.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000264829.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000264853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000264859.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000264860.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000264868.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000264895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000264940.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000264954.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000265055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000265091.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000265113.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000265130.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000265142.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000265204.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000265218.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000265334.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000265349.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000265394.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000265490.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000265490.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000265519.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000265519.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000265656.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000265728.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000265787.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000265845.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000265912.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000265912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000265943.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000266088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000266111.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000266111.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000266120.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000266126.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000266149.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000266256.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000266278.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000266402.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000266456.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000266466.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000266469.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000266644.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000266644.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000266651.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000266667.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000266677.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000266718.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000266783.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000266801.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000266824.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000266869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000266877.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000266912.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000266912.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000266913.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000266922.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000266925.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000266926.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000266936.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000266957.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000266965.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000266969.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000266970.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000266994.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000266999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000267003.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000267016.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000267018.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000267018.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000267026.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000267040.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000267040.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000267042.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000267042.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000267065.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000267067.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000267079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000267093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000267096.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000267100.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000267112.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000267117.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000267149.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000267149.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000267149.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000267150.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000267163.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000267174.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000267183.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000267183.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000267191.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000267212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000267213.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000267255.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000267263.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000267288.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000267288.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000267289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000267296.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000267306.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000267308.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000267311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000267313.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000267321.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000267344.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000267344.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000267348.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000267348.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000267383.2 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000267383.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000267394.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000267397.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000267414.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000267446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000267474.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000267476.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000267481.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000267505.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000267505.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000267505.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000267519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000267560.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000267567.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000267583.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000267605.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000267649.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000267662.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000267672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000267682.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000267758.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000267778.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000267783.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000267787.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000267798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000267804.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000267904.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000267919.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000267922.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000267927.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000267939.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000267939.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000268087.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000268189.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000268340.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000268355.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000268355.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000268355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000268366.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000268401.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000268499.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000268564.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000268573.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000268583.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000268583.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000268613.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000268683.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000268764.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000268812.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000268913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000268931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000268938.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000268970.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000269019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000269082.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000269102.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000269148.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000269172.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000269202.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000269235.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000269235.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000269290.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000269293.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000269321.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000269321.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000269386.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000269392.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000269399.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000269425.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000269427.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000269439.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000269444.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000269463.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000269483.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000269486.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000269486.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000269487.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000269574.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000269614.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000269652.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000269652.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000269656.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000269680.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000269694.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000269806.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000269814.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000269843.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000269867.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000269887.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000269887.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000269896.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000269908.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000269923.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000269924.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000269924.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000269925.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000269934.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000269946.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000269949.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000269951.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000269956.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000269956.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000269980.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000269989.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000269994.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000269996.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000269997.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000269997.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000270000.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000270006.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000270020.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000270031.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000270031.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000270031.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000270036.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000270048.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000270061.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000270072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000270084.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000270091.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000270100.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000270104.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000270108.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000270115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000270117.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000270123.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000270124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000270137.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000270173.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000270174.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000270190.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000270190.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000270190.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000270210.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000270265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000270457.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000270704.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000270720.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000270720.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000270742.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000270828.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000270933.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000270951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000270951.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000271032.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000271185.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000271200.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000271200.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000271218.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000271228.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000271252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000271265.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000271270.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000271314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000271334.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000271344.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000271347.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000271366.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000271367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000271427.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000271430.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000271538.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000271551.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000271579.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000271646.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000271716.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000271722.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000271732.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000271734.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000271757.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000271778.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000271782.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000271788.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000271824.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000271826.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000271843.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000271882.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000271889.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000271913.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000271914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000271914.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000271916.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000271917.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000271921.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000271926.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000271930.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000271948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000271948.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000271948.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000271967.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000271975.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000271978.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000271983.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000272023.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000272029.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000272033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000272057.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000272057.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000272070.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000272079.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272092.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000272102.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000272102.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000272109.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000272109.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000272123.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000272128.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000272130.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272141.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000272144.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000272148.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000272156.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000272158.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000272191.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000272203.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000272236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000272240.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000272243.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272248.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000272254.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000272255.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000272263.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000272346.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000272362.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000272370.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000272373.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000272373.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000272374.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000272374.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000272375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000272384.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272411.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272416.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000272426.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000272449.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000272449.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000272452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000272452.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000272465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000272482.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000272483.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000272483.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000272489.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000272505.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000272508.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000272518.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000272520.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000272524.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000272525.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000272529.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000272554.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000272556.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000272562.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000272588.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272604.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000272620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000272630.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000272639.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000272650.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000272682.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000272689.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000272691.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272692.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000272695.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272695.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000272696.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000272699.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000272715.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Afatinib |
ENSG00000272717.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272732.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272754.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000272760.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000272788.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000272796.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000272808.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000272812.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000272824.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272825.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000272834.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000272862.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000272894.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272917.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272931.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000272942.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000272949.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000272954.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000272970.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000272977.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000272983.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000272983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000272983.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000272993.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000273000.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000273007.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000273007.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000273009.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000273009.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000273011.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000273026.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000273033.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000273056.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000273056.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000273056.1 |
Predicted lncRNA |
Sarcoma |
|
| Afatinib |
ENSG00000273058.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000273059.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000273065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000273076.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000273077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000273081.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000273091.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000273096.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000273096.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000273116.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000273125.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000273174.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000273175.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000273186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000273188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000273188.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000273193.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000273203.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Afatinib |
ENSG00000273209.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000273216.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000273232.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000273233.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Afatinib |
ENSG00000273240.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000273243.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000273247.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000273248.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000273253.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Afatinib |
ENSG00000273257.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000273264.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000273281.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000273338.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000273341.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000273343.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000273344.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000273350.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000273350.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000273366.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Afatinib |
ENSG00000273369.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000273374.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Afatinib |
ENSG00000273381.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Afatinib |
ENSG00000273399.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Afatinib |
ENSG00000273399.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Afatinib |
ENSG00000273399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000273443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000273443.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000273447.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Afatinib |
ENSG00000273464.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Afatinib |
ENSG00000273483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
ENSG00000273486.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000273488.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Afatinib |
ENSG00000273493.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Afatinib |
miR-146a |
Curated miRNA |
non-small cell lung cancer |
|